Should you consider adding Dulux to your portfolio?

Dulux is well placed to reward shareholders as the home improvement market continues to show strength.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australians love to do their own home improvements, especially as interest in house and unit sales gathers momentum. Furthermore, even when times are tough there is always need for consumers to spend on home maintenance.

As a manufacturer and marketer of several well-known branded products, Dulux (ASX: DLX) operates throughout Australia, New Zealand, Papua New Guinea and southeast Asia, including China.  The company is a household name, as the leading manufacturer of premium decorative paint and surface coatings. It is also a conglomerate of several well-known brands including, Yates, Selby and Alesco.

Importantly Dulux is the dominant paint provider for Bunnings warehouses.  Accordingly, it is linked  to Wesfarmers' (ASX: WES) Bunnings success story, as existing store sales increase and new warehouses are established throughout Australia and New Zealand.

Dulux has a strategy to protect and expand leading brand positions in Australia and New Zealand.  Recently it has been on the acquisition trail. In December 2012, takeover of the garage door specialist Alesco was completed. With cost and revenue synergies, this and other acquisitions are well positioned to generate strong returns. Therefore the recovery in housing sales, both new and existing, supports growth for this company through its several branded products.

Over the last three years there has been significant growth per share as measured by sales, earnings and dividends. In addition, return on equity is consistently high, although last financial year it was 41.6% compared to 43.8% previously. Nonetheless, these returns on equity are impressive.

It should be mentioned, however, that such growth does not come without risk. In particular, recent acquisitions have meant that debt is relatively high, although interest cover in the latest annual report was 5.36. This should be acceptable to most investors.

Foolish takeaway

This stock is not going to the moon but should provide reasonable dividend and share price growth for the medium- to long-term investor.

Motley Fool contributor Chris Koenig does not own shares in any company mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »